{"id":"NCT00541450","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)","officialTitle":"A Phase III Randomized, Active-Comparator (Pioglitazone) Controlled Clinical Trial to Study the Efficacy and Safety of Sitagliptin and MK0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01-15","primaryCompletion":"2010-01-08","completion":"2010-01-16","firstPosted":"2007-10-10","resultsPosted":"2011-04-14","lastUpdate":"2017-05-12"},"enrollment":492,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Comparator: sitagliptin phosphate (sitagliptin)","otherNames":["MK0431, Januvia™"]},{"type":"DRUG","name":"sitagliptin phosphate (+) metformin hydrochloride","otherNames":["MK-0431A, Janumet™"]},{"type":"DRUG","name":"Comparator: pioglitazone","otherNames":["Actos®"]},{"type":"DRUG","name":"Matching placebo to pioglitazone","otherNames":[]},{"type":"DRUG","name":"Matching placebo to sitagliptin","otherNames":[]},{"type":"DRUG","name":"Matching Placebo to Sita/Met FDC","otherNames":[]}],"arms":[{"label":"Sita/Met FDC","type":"EXPERIMENTAL"},{"label":"Pioglitazone","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of sitagliptin and MK0431A in comparison to a commonly used medication in patients with type 2 diabetes.","primaryOutcome":{"measure":"Change in Hemoglobin A1c (A1C) in the Sita/Met Fixed-Dose Combination (FDC) or Pioglitazone Groups at 40 Weeks","timeFrame":"Baseline to 40 weeks","effectByArm":[{"arm":"Sita/Met FDC","deltaMin":-1.75,"sd":null},{"arm":"Pioglitazone","deltaMin":-1.38,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.002"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21849007"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":244},"commonTop":["Nasopharyngitis","Headache","Oedema peripheral"]}}